HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu-Jen Chen Selected Research

Doxorubicin (Adriamycin)

1/2023Treatment Resulting Changes in Volumes of High-18F-FDG-Uptake Adipose Tissues over Orbit and Epicardium Correlate with Treatment Response for Non-Hodgkin's Lymphoma.
3/2016CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells.
1/2013The inhibitory effect of ellagic Acid on cell growth of ovarian carcinoma cells.
1/2012Small-molecule synthetic compound norcantharidin reverses multi-drug resistance by regulating Sonic hedgehog signaling in human breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu-Jen Chen Research Topics

Disease

106Neoplasms (Cancer)
03/2024 - 04/2002
17Hepatocellular Carcinoma (Hepatoma)
12/2023 - 03/2005
17Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 06/2006
14Leukemia
04/2023 - 03/2005
14Body Weight (Weight, Body)
08/2022 - 07/2004
12Neoplasm Metastasis (Metastasis)
02/2023 - 12/2003
12Adenocarcinoma
10/2022 - 01/2004
12Squamous Cell Carcinoma of Head and Neck
06/2021 - 12/2011
10Esophageal Neoplasms (Esophageal Cancer)
02/2020 - 09/2005
8BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2023 - 01/2011
8Colorectal Neoplasms (Colorectal Cancer)
04/2020 - 01/2008
8Carcinoma (Carcinomatosis)
12/2016 - 06/2006
7Pain (Aches)
01/2019 - 11/2003
7Lung Neoplasms (Lung Cancer)
01/2018 - 06/2004
6Breast Neoplasms (Breast Cancer)
01/2022 - 11/2003
6Obesity
07/2021 - 01/2008
6Inflammation (Inflammations)
05/2021 - 01/2014
6Ataxia Telangiectasia (Louis Bar Syndrome)
01/2020 - 09/2007
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2014 - 01/2008
5Fibrosis (Cirrhosis)
01/2024 - 12/2009
5Infections
05/2023 - 03/2008
5Diarrhea
01/2022 - 02/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 12/2005
5Mouth Neoplasms (Oral Cancer)
02/2019 - 01/2017
4Colonic Neoplasms (Colon Cancer)
03/2024 - 12/2016
4Stroke (Strokes)
01/2024 - 01/2018
4Melanoma (Melanoma, Malignant)
05/2023 - 01/2013
4Esophageal Squamous Cell Carcinoma
02/2023 - 01/2019
4Prostatic Neoplasms (Prostate Cancer)
01/2023 - 01/2018
4Polyploidy
10/2022 - 09/2009
4Rectal Neoplasms (Rectal Cancer)
08/2022 - 09/2006
4Thrombosis (Thrombus)
01/2022 - 01/2009
4Metabolic Syndrome (Dysmetabolic Syndrome X)
07/2021 - 12/2012
4Heart Failure
06/2021 - 05/2017
4Glioblastoma (Glioblastoma Multiforme)
03/2015 - 09/2012
4Glioma (Gliomas)
03/2015 - 07/2008
3Atrial Fibrillation
01/2024 - 05/2017
3Type 2 Diabetes Mellitus (MODY)
02/2023 - 04/2018
3Carcinogenesis
11/2022 - 01/2014
3Wounds and Injuries (Trauma)
10/2022 - 11/2003
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2022 - 09/2010
3Hypopharyngeal Neoplasms
10/2022 - 06/2005
3Fatigue
08/2022 - 01/2019
3Mucositis
05/2021 - 08/2005
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2020 - 10/2013
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2015 - 10/2008

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2024 - 02/2016
11Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2007
11Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 01/2004
8norcantharidinIBA
06/2015 - 03/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2023 - 06/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2009
7Cisplatin (Platino)FDA LinkGeneric
03/2017 - 09/2005
6InflammasomesIBA
01/2023 - 10/2016
6CytokinesIBA
05/2021 - 06/2006
6caffeic acid phenethyl esterIBA
01/2017 - 12/2003
5AlbuminsIBA
01/2024 - 12/2009
5Messenger RNA (mRNA)IBA
10/2022 - 07/2008
5Transforming Growth Factors (Transforming Growth Factor)IBA
11/2020 - 08/2005
5Radiation-Sensitizing AgentsIBA
02/2019 - 11/2003
5CreatinineIBA
02/2018 - 08/2005
5Telomerase (Telomerase Reverse Transcriptase)IBA
03/2014 - 07/2006
4BilirubinIBA
01/2024 - 10/2021
4Indicators and Reagents (Reagents)IBA
01/2024 - 11/2012
46-(Methylsulfinyl)hexyl isothiocyanateIBA
04/2023 - 01/2014
4Oxygen (Dioxygen)IBA
04/2023 - 01/2018
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023 - 01/2012
4tetrandrineIBA
01/2022 - 12/2002
4Sorafenib (BAY 43-9006)FDA Link
12/2020 - 01/2009
4armillaridinIBA
01/2019 - 01/2013
4Alanine Transaminase (SGPT)IBA
02/2018 - 08/2005
4Phosphotransferases (Kinase)IBA
01/2016 - 05/2009
4WW Domain-Containing OxidoreductaseIBA
03/2015 - 09/2012
4Tyrosine Kinase InhibitorsIBA
07/2014 - 09/2009
4Cantharidin (Cantharides)IBA
01/2013 - 03/2005
3midostaurinIBA
10/2022 - 09/2009
3Peptides (Polypeptides)IBA
10/2022 - 01/2014
3ferric oxide (iron oxide)IBA
10/2022 - 11/2013
3Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 11/2008
3CaspasesIBA
02/2020 - 01/2008
3Leucovorin (Folinic Acid)FDA Link
01/2020 - 09/2006
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 05/2009
3Annexin A5IBA
01/2020 - 04/2012
3Checkpoint Kinase 2IBA
02/2019 - 05/2009
3Conditioned Culture MediaIBA
02/2018 - 11/2008
3CateninsIBA
01/2018 - 01/2013
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
02/2017 - 12/2012
3Propolis (Bee Bread)IBA
01/2017 - 01/2008
3Lapatinib (GW572016)FDA Link
01/2016 - 01/2011
3Contrast MediaIBA
01/2016 - 11/2013

Therapy/Procedure

50Radiotherapy
11/2023 - 04/2002
34Therapeutics
01/2024 - 12/2002
17Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2022 - 01/2009
16Chemoradiotherapy
10/2022 - 09/2005
12Drug Therapy (Chemotherapy)
05/2021 - 06/2005
6Neoadjuvant Therapy
02/2023 - 10/2016
5Aftercare (After-Treatment)
11/2020 - 11/2003
4Chinese Traditional Medicine (Traditional Chinese Medicine)
10/2017 - 10/2009
4Brachytherapy
02/2016 - 10/2007
3Immunotherapy
10/2022 - 01/2008